High Drug Costs Resources
Talking Points
- Cost-sharing Caps Don’t Solve the Problem of High Drug Prices
- Drug Manufacturer Coupons in Medicare Part D
- Drug Manufacturers Should Stop Playing Games and Lower Prices (2021)
- Explaining Manufacturer Coupons and Assistance Programs (2021)
- Five Facts on Insulin
- One Percent Steps, Eliminating Prescription Drug Copay Coupons - Commercial (2021)
- One Percent Steps, Reforming the Orphan Drug Act Saves 1.5 of Total Drug Spending (2021)
- PBMs Are Innovating to Increase Affordable Access to Insulin
- PCMA, 21 Solutions to High Drug Costs for 2021 (2021)
White Papers and Presentations
- Primer, Payor Approaches to Reducing the Harm of Manufacturer Coupons (2021)
- Primer, Manufacturer Coupons and Payor Strategies (2021)
- Primer, Insulins - Prices, Rebates, and Factors Influencing Costs (2018)
- Primer, Drug Manufacturer Coupons (2021)
- Primer, Manufacturer Coupons and Payor Strategies (2021)
- Primer, Payor Approaches to Reducing the Harm of Manufacturer Coupons (2021)
- Primer, Drug Manufacturer Coupons (2021)
ALL CONTENT ON THIS PAGE IS CONFIDENTIAL, for INTERNAL PCMA USE ONLY
